Nanomedicines are focus of new approach
Posted: Mon Feb 22, 2016 5:21 am
Parvus Therapeutics has announced the publication in Nature of a paper describing the discovery and applications of a novel therapeutic approach employing nanomedicines, referred to as Navacims, to reprogram white blood cells to become regulatory cells capable of blunting autoimmune responses and restoring the equilibrium of the immune system...Read more - http://www.ms-uk.org/MSnews